בורטז טבע 3.5 מ"ג
BORTEZ TEVA 3.5 MG

פעילות רפואית

לתכשיר קיים עלון לרופא בלבד. ההתוויה המאושרת: Bortez Teva 3.5mg is indicated for the treatment of patients with multiple myeloma. Bortez Teva 3.5mg is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortez Teva 3.5mg in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.